National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 81551-81552 [2015-32771]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 250 / Wednesday, December 30, 2015 / Notices
determine whether their food products
are subject to these regulations by
providing for voluntary submission of
process filings by processors of nonacidified foods (e.g., some acid foods or
fermented foods), and by helping
processors of acidified foods in ensuring
safe manufacturing, processing, and
packing processes and in employing
appropriate quality control procedures.
We are withdrawing the draft guidance,
in part, because many of the topics
addressed in the draft guidance are now
being addressed in other documents.
DATES: The withdrawal is effective
December 30, 2015.
FOR FURTHER INFORMATION CONTACT:
Michael Mignogna, Center for Food
Safety and Applied Nutrition (HFS–
302), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740, 240–402–1565.
SUPPLEMENTARY INFORMATION: In a notice
published in the Federal Register of
September 27, 2010 (75 FR 59268), we
announced the availability of a draft
guidance entitled ‘‘Draft Guidance for
Industry: Acidified Foods’’ and gave
interested parties an opportunity to
submit comments by December 27,
2010, for us to consider before
beginning work on the final version of
the guidance. The draft guidance was
intended to complement our regulations
regarding acidified foods (including
regulations for specific current good
manufacturing practice (21 CFR part
114), establishment registration (21 CFR
108.25(c)(1)), and process filing (21 CFR
108.25(c)(2)) by helping commercial
food processors in determining whether
their food products are subject to these
regulations and by providing for
voluntary submission of process filings
by processors who conclude that their
products are non-acidified foods (e.g.,
acid foods or fermented foods). The
draft guidance also was intended to help
processors of acidified foods in ensuring
safe manufacturing, processing, and
packing processes and in employing
appropriate quality control procedures.
We are withdrawing the draft
guidance, in part, because the
procedures for voluntary submission of
process filings by processors of nonacidified foods are addressed by our
recently issued guidance entitled
‘‘Submitting Form FDA 2541 (Food
Canning Establishment Registration)
and Forms FDA 2541d, FDA 2541e,
FDA 2541f, and FDA 2541g (Food
Process Filing Forms) to FDA in
Electronic or Paper Format’’ (80 FR
60909, October 8, 2015). We also are
withdrawing the draft guidance, in part,
because we recently issued a final rule
entitled ‘‘Current Good Manufacturing
VerDate Sep<11>2014
17:59 Dec 29, 2015
Jkt 238001
Practice, Hazard Analysis, and RiskBased Preventive Controls for Human
Food’’ (80 FR 55908, September 17,
2015), and that rule, along with
guidance documents we are developing
as a companion to that rule, should help
processors in ensuring safe
manufacturing, processing, and packing
processes and in employing appropriate
quality control procedures.
Dated: December 23, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–32781 Filed 12–29–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). The
Advisory Council on Alzheimer’s
Research, Care, and Services provides
advice on how to prevent or reduce the
burden of Alzheimer’s disease and
related dementias on people with the
disease and their caregivers. During the
January meeting, the Advisory Council
will review the process for developing
recommendations and developing the
National Plan to Address Alzheimer’s
Disease, discuss updates to work on
Goals 2 and 3 of the National Plan, and
hear updates on a future summit on
care.
DATES: The meeting will be held on
January 25, 2016 from 9:30 a.m. to 5:00
p.m. EDT.
ADDRESSES: The meeting will be held in
Room 6, Building 31 of the National
Institutes of Health, 9000 Rockville
Pike, Bethesda, Maryland 20892.
Comments: Time is allocated in the
afternoon on the agenda to hear public
comments. The time for oral comments
will be limited to two (2) minutes per
individual. In lieu of oral comments,
formal written comments may be
submitted for the record to Rohini
Khillan, ASPE, 200 Independence
Avenue SW., Room 424E, Washington,
DC 20201. Comments may also be sent
to napa@hhs.gov. Those submitting
written comments should identify
themselves and any relevant
organizational affiliations.
FOR FURTHER INFORMATION CONTACT:
Rohini Khillan (202) 690–5932,
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
81551
rohini.khillan@hhs.gov. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
napa@hhs.gov and put ‘‘January 25
Meeting Attendance’’ in the Subject line
by Friday, January 15, so that their
names may be put on a list of expected
attendees and forwarded to the security
officers at the National Institutes of
Health. Any interested member of the
public who is a non-U.S. citizen should
include this information at the time of
registration to ensure that the
appropriate security procedure to gain
entry to the building is carried out.
Although the meeting is open to the
public, procedures governing security
and the entrance to Federal buildings
may change without notice. If you wish
to make a public comment, you must
note that within your email.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting:
During the January meeting, the
Advisory Council will review the
process for developing
recommendations and developing the
National Plan to Address Alzheimer’s
Disease, discuss updates to work on
Goals 2 and 3 of the National Plan, and
hear updates on a future summit on
care.
Procedure and Agenda: This meeting
is open to the public. Please allow 45
minutes to go through security and walk
to the meeting room. The meeting will
also be webcast at www.hhs.gov/live.
Authority: 42 U.S.C. 11225; Section
2(e)(3) of the National Alzheimer’s
Project Act. The panel is governed by
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which
sets forth standards for the formation
and use of advisory committees.
Dated: December 21, 2015.
Richard G. Frank,
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2015–32890 Filed 12–29–15; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
E:\FR\FM\30DEN1.SGM
30DEN1
81552
Federal Register / Vol. 80, No. 250 / Wednesday, December 30, 2015 / Notices
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: January 27, 2016.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Room
8C100, 5601 Fishers Lane, Rockville, MD
20892, (Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G51, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–507–9685,
thomas.conway@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Investigator Initiated
Clinical Trials.
Date: January 27, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Raymond R. Schleef,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3E61, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5019, schleefrr@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 23, 2015.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32771 Filed 12–29–15; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: January 22, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Room
3C100, 5601 Fishers Lane, Rockville, MD
20892, (Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G51, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–507–9685,
thomas.conway@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Clinical Trial Implementation Cooperative
Agreement (U01).
Date: January 22, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Zhuqing (Charlie) Li,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room # 3G41B, National Institutes
of Health/NIAID, 5601 Fishers Lane,
MSC9823, Bethesda, MD 20892–9823, (240)
669–5068, zhuqing.li@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; SBIR Review Meeting Topic
14.
Date: February 5, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health, 6701 Democrary Blvd.,
Democracy 1, Room 1073, Bethesda, MD
20892, 301–594–9459, lourdes.ponce@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 23, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32765 Filed 12–29–15; 8:45 am]
BILLING CODE 4140–01–P
Dated: December 23, 2015.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–32767 Filed 12–29–15; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Government-Owned Inventions;
Availability for Licensing and CoDevelopment
BILLING CODE 4140–01–P
17:59 Dec 29, 2015
Jkt 238001
National Institutes of Health.
Notice.
AGENCY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
National Institutes of Health
ACTION:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
E:\FR\FM\30DEN1.SGM
30DEN1
]]>Agencies
[Federal Register Volume 80, Number 250 (Wednesday, December 30, 2015)]
[Notices]
[Pages 81551-81552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32771]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
[[Page 81552]]
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
Date: January 27, 2016.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Room 8C100, 5601 Fishers
Lane, Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G51, National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, 240-507-9685,
thomas.conway@nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Investigator Initiated Clinical
Trials.
Date: January 27, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Raymond R. Schleef, Ph.D., Senior Scientific
Review Officer, Scientific Review Program, Division of Extramural
Activities, Room 3E61, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5019,
schleefrr@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 23, 2015.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32771 Filed 12-29-15; 8:45 am]
BILLING CODE 4140-01-P
